Cart
sales@molnova.com
Phaseoloidin
CAS No. 118555-82-1
Phaseoloidin( —— )
Catalog No. M20380 CAS No. 118555-82-1
Phaseoloidin a homogentisic acid glucoside from Nicotiana attenuata trichomes contributes to the plant's resistance against lepidopteran herbivores.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 77 | In Stock |
|
| 10MG | 111 | In Stock |
|
| 25MG | 178 | In Stock |
|
| 50MG | 265 | In Stock |
|
| 100MG | 401 | In Stock |
|
| 500MG | 888 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePhaseoloidin
-
NoteResearch use only, not for human use.
-
Brief DescriptionPhaseoloidin a homogentisic acid glucoside from Nicotiana attenuata trichomes contributes to the plant's resistance against lepidopteran herbivores.
-
DescriptionPhaseoloidin a homogentisic acid glucoside from Nicotiana attenuata trichomes contributes to the plant's resistance against lepidopteran herbivores.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number118555-82-1
-
Formula Weight330.29
-
Molecular FormulaC14H18O9
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (302.76 mM)
-
SMILESOC[C@H]1O[C@@H](Oc2ccc(O)cc2CC(O)=O)[C@H](O)[C@@H](O)[C@@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Weinhold A Shaker K Wenzler M et al. Phaseoloidin a homogentisic acid glucoside from Nicotiana attenuata trichomes contributes to the plant's resistance against lepidopteran herbivores[J].J Chem Ecol. 2011 Oct;37(10):1091-8.
molnova catalog
related products
-
1-Hydroxy-2-naphthoi...
Metabolite from phenanthrene degradation.
-
PQ-912
PQ-912 (PQ 912, PQ912)?is a potent glutaminyl cyclase (QC) inhibitor that inhibits human, rat, and mouse QC with Ki of 20-65 nM.
-
GS-6620 PM
GS-6620 PM is a derivative of GS-6620, an orally administered anti-hepatitis C virus polymerase inhibitor and a novel potent C-nucleoside adenine analogue monophosphate prodrug.
